8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):
April 18, 2007 (April 17, 2007)

NATIONAL HEALTH INVESTORS, INC.

(Exact name of registrant as specified in its charter)

Maryland	001-10822	62-1470956
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

100 Vine Street, Suite 1202
Murfreesboro, TN 37130
(Address of principal executive offices)

(615) 850-9100
(Registrant’s telephone number, including area code)

Not Applicable
(Former name, former address and former fiscal year,
if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01. Other Events.

     On April 17, 2007, National Health Investors, Inc. (the “Company”) issued a press release in response to apparent market rumors and the large volume of trades in its stock. The press release announced that the Company is engaged in preliminary discussions and the exchange of information regarding a possible combination of interests with another company. The press release is attached hereto as Exhibit 99, which is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Number		Exhibit
	99	Press Release dated April 17, 2007.

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

NATIONAL HEALTH INVESTORS, INC.
By:	/s/ Richard F. LaRoche, Jr.
	Name:	Richard F. LaRoche, Jr.
	Title:	Chairman of Special Committee

Date: April 18, 2007

EX-99

Exhibit 99

For Immediate Release

Contact:	National Health Investors, Inc.
	Richard F. LaRoche, Jr.
	Chairman of Special Committee
Telephone:	(615) 893-8490

NATIONAL HEALTH INVESTORS, INC. ANNOUNCES PRELIMARY DISCUSSIONS

MURFREESBORO, TN (April 17, 2007) — In response to apparent market rumors and the large volume of trades in its stock today, National Health Investors, Inc. (NYSE: NHI) announced that it is engaged in preliminary discussions and the exchange of information regarding a possible combination of interests with another company. There can be no assurance that any transaction will occur, or as to the timing, structure or terms of any transaction. The company will have no further comment until an agreement is reached or the discussions are terminated.

NHI specializes in the financing of health care real estate by first mortgage and by purchase and leaseback transactions. The common stock of National Health Investors trades on the New York Stock Exchange with the symbol NHI. Additional information including NHI’s most recent press releases may be obtained on our web site at www.nhinvestors.com.

Statements in this press release that are not historical facts are forward-looking statements. These statements include comments regarding possibilities of continuing discussions between the companies and involve risks and uncertainties, including that there may be no further discussions or any transaction. NHI does not undertake any obligation to update forward-looking statements. There will be no update as to the status of negotiations with respect to a potential transaction unless required to by law. NHI cautions investors that any forward-looking statements made involve risks and uncertainties and are not guarantees of future performance. All forward-looking statements represent the respective company’s judgment as of the date of this release.

P.O. Box 1102 Murfreesboro TN 37133-1102 — City Center 100 Vine Street Murfreesboro TN 37130
Phone (615) 890-9100